First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study

Published:2016-11-22 Issue:4 Volume:35 Page:671-678
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Meunier Godelieve¹,Ysebaert Loic²,Nguyen-Thi Phi Linh¹,Lepretre Stéphane³,Quinquenel Anne⁴,Dupuis Jehan⁵,Lemal Richard⁶,Aurran Thérèse⁷,Tomowiak Cécile⁸,Cymbalista Florence⁹,Dilhuydy Marie Sarah¹⁰,Brion Annie¹¹,Morel Pierre¹²,Cazin Bruno¹³,Leblond Véronique¹⁴,Cartron Guillaume¹⁵,Ré Daniel¹⁶,Béné Marie Christine¹⁷,Michallet Anne Sophie¹⁸,Feugier Pierre¹

Affiliation:

1. Nancy University Hospital; France

2. Toulouse University Cancer Hospital; France

3. Rouen Henri Becquerel Cancer Center; France

4. Reims University Hospital; France

5. Creteil Henri Mondor University Hospital; France

6. Clermont-Ferrand Estaing University Hospital; France

7. Marseille Paoli Calmettes Cancer Center; France

8. Poitiers University Hospital; France

9. Bobigny Avicenne University Hospital; France

10. Bordeaux University Hospital; France

11. Besançon Jean-Minjoz University Hospital; France

12. Lens General Hospital; France

13. Lille University Hospital; France

14. Paris la Pitié Salpêtrière University Hospital; France

15. Montpellier University Hospital; France

16. Antibes General Hospital; France

17. Nantes Hôtel-Dieu University Hospital; France

18. Lyon Léon Bérard Cancer Center; France

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference39 articles.

1. Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database;Satram-Hoang;Ann Hematol,2014

2. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France;Monnereau;Int J Cancer,2013

3. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers;Shanafelt;Hematology Am Soc Hematol Educ Program,2013

4. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience;Abrisqueta;Blood,2009

5. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century;Brenner;Blood,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study;International Journal of Environmental Research and Public Health;2021-01-15

2. Chronic lymphoid leukemia in patients over 80 years of age: at last prospective data on patient characteristics and treatment!;HEMATOLOGIE;2019

3. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia;British Journal of Haematology;2018-11-21

4. Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study;Diabetes Care;2018-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3